Sponsor Pipeline

Fusion Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05219500 Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of… Metastatic Castration Resistant Prostate Cancer Active, Not Recruiting
NCT06402331 FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant… Metastatic Castration-resistant Prostate Cancer Active, Not Recruiting
NCT06909825 FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant… Metastatic Castration-resistant Prostate Cancer Active, Not Recruiting
Disease Areas
Prostate Cancer (3)
Get alerts when Fusion Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free